The chemical substance known as Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N′-[5-(6-quinolinyl)-1H-pyrazol-3-yl]- is a complex organic compound characterized by its urea functional group, which is central to its structure. This compound features multiple pyrazole rings, which contribute to its potential biological activity and interactions. The presence of substituents such as tert-butyl and 4-methylphenyl groups enhances its lipophilicity, potentially influencing its solubility and permeability in biological systems. Additionally, the quinoline moiety may impart unique pharmacological properties, making it of interest in medicinal chemistry. The compound's molecular structure suggests it may engage in hydrogen bonding and other intermolecular interactions, which are critical for its reactivity and stability. Overall, this substance is likely to be investigated for its potential applications in pharmaceuticals or agrochemicals, given the structural motifs associated with bioactivity.

Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N′-[5-(6-quinolinyl)-1H-pyrazol-3-yl]-

1271418-15-5: The chemical substance known as Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N′-[5-(6-quinolinyl)-1H-pyrazol-3-yl]- is a complex organic compound characterized by its urea functional group, which is central to its structure. This compound features multiple pyrazole rings, which contribute to its potential biological activity and interactions. The presence of substituents such as tert-butyl and 4-methylphenyl groups enhances its lipophilicity, potentially influencing its solubility and permeability in biological systems. Additionally, the quinoline moiety may impart unique pharmacological properties, making it of interest in medicinal chemistry. The compound's molecular structure suggests it may engage in hydrogen bonding and other intermolecular interactions, which are critical for its reactivity and stability. Overall, this substance is likely to be investigated for its potential applications in pharmaceuticals or agrochemicals, given the structural motifs associated with bioactivity.

<p>Pyk2-IN-2 (compound 13j) acts as a Pyk2 inhibitor, exhibiting an IC 50 value of 0.608 μM for FAK kinase [1].</p>

CAS 1271418-15-5

Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N′-[5-(6-quinolinyl)-1H-pyrazol-3-yl]-

Pyk2-IN-2

Ref: TM-T87280